Similar findings have been observed in HCC cell lines [45], and diabetic mice treated with the selective DPP4 inhibitor MK-0626 similarly exhibited a ~4-fold increase in circulating DPP4 [27]. Here, DPP4 is linked to hepatocellular carcinoma.